BETTERLIFE PHARMA INC.: retained earnings or deficit
Retained earnings or deficit for BETTERLIFE PHARMA INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BETTERLIFE PHARMA INC. financial histories
What this measure means
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
Exact concept: us-gaap:RetainedEarningsAccumulatedDeficit. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2013-01-31 to 2019-01-31. The SEC response was captured on 2026-09-20.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Coverage by original unit
- CAD: 2014-01-31 to 2019-01-31. This unit’s selected history ends more than two years before capture.
- USD: 2013-01-31 to 2018-01-31. This unit’s selected history ends more than two years before capture.
These are separate reported series. A newer period in one unit does not update another unit’s history or establish a currency conversion.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2019-01-31 | -34,963,335 | CAD | 2019-05-03 | 10-K · 0001477932-19-002311 |
| At date | 2018-01-31 | -25,816,964 | CAD | 2019-05-03 | 10-K · 0001477932-19-002311 |
| At date | 2015-01-31 | -4,171,294 | CAD | 2015-06-17 | 10-K · 0001477932-15-003905 |
| At date | 2014-01-31 | -2,914,247 | CAD | 2015-06-17 | 10-K · 0001477932-15-003905 |
| At date | 2018-01-31 | -20,718,935 | USD | 2018-05-01 | 10-K · 0001477932-18-002135 |
| At date | 2017-01-31 | -20,597,753 | USD | 2018-05-01 | 10-K · 0001477932-18-002135 |
| At date | 2016-01-31 | -14,319,546 | USD | 2017-04-28 | 10-K · 0001477932-17-002007 |
| At date | 2015-01-31 | -4,012,481 | USD | 2016-06-07 | 10-K/A · 0001477932-16-010741 |
| At date | 2013-01-31 | 2,160,372 | USD | 2013-05-16 | 10-K · 0001511164-13-000237 |
Related financial histories
- BETTERLIFE PHARMA INC.: total assets
- BETTERLIFE PHARMA INC.: total liabilities
- BETTERLIFE PHARMA INC.: stockholders equity
- BETTERLIFE PHARMA INC.: cash and cash equivalents
- BETTERLIFE PHARMA INC.: net income or loss
- BETTERLIFE PHARMA INC.: operating cash flow
- BETTERLIFE PHARMA INC.: financing cash flow
- BETTERLIFE PHARMA INC.: basic weighted-average shares
- BETTERLIFE PHARMA INC.: net property, plant and equipment
- BETTERLIFE PHARMA INC.: share-based compensation expense
- BETTERLIFE PHARMA INC.: operating income or loss
- BETTERLIFE PHARMA INC.: current assets
- BETTERLIFE PHARMA INC.: interest expense
- BETTERLIFE PHARMA INC.: current liabilities
- BETTERLIFE PHARMA INC.: operating expenses
Inspect the source
- Entity
- BETTERLIFE PHARMA INC. / CIK 0001464165
- Captured
- 2026-09-20T09:06:34.124Z
- SEC response SHA-256
da89258f023cbc29ad1ecdd31014873fa96a7739fba3e7b66a8b80f8715d36cf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001464165.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))